Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SMMT
SMMT logo

SMMT News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

SMMT News

Investigation into Summit Therapeutics by Johnson Fistel

May 04 2026Globenewswire

Summit Reports Q1 2026 Net Loss Exceeding Expectations

May 01 2026stocktwits

Summit Therapeutics' Clinical Trial Update

May 01 2026seekingalpha

Summit Therapeutics Reports Wider Q1 Loss and Clinical Progress

May 01 2026NASDAQ.COM

Summit Therapeutics Q1 Earnings Beat Expectations

Apr 30 2026seekingalpha

Summit Therapeutics Reports Q1 2026 Financial Results and Clinical Updates

Apr 30 2026Newsfilter

Aehr Test Systems and MongoDB Show Active Options Trading

Apr 16 2026NASDAQ.COM

Stifel Begins Coverage of Summit Therapeutics Inc with a Buy Rating and Sets Price Target at $45

Apr 08 2026moomoo

SMMT Events

05/01 16:10
Apple Raises Quarterly Dividend and Announces $100B Stock Buyback
The major averages had a mixed first day of May following the latest slate of corporate earnings results. First quarter results are coming in strong and big tech continues to carry the tape. Meanwhile, oil prices slipped after Iran reportedly issued a response through Pakistan mediators to the latest U.S. amendments to a draft agreement to end the war.Additionally, President Trump announced via Truth Social that he plans to increase tariffs charged to the EU for cars and trucks coming into the U.S. to 25%. In his post on the matter, the president accused the EU of "not complying" with a previous trade deal.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Applereported, gave a better-than-expected forecast, raised its quarterly dividend, and announced an additional $100B stock repurchase programSanDiskand Western Digitalboth reportedwith upbeat outlooksExxon Mobiland Chevronboth reportedMultiple analystsRobloxfollowing its quarterly reportRedditreported better-than-expected2. WALL STREET CALLS:Robloxat Raymond James, BofA and BTIG after a guidance resetHersheyto Buy at TD CowenCaterpillarto Equal Weight at Morgan StanleyParamount Skydanceat Overweight from Underweight at Morgan StanleyElf Beautyto Equal Weight at Morgan Stanley3. AROUND THE WEB:Metaacquired AI robot startup Assured Robot Intelligence, Bloomberg reportsNew Trump Mediachief faces business mix challenge, WSJ reportsKKRhas secured over $10B to launch Helix Digital, a company that will design, build, own and run infrastructure for AI, Bloomberg saysLululemon'sboard members have been under pressure, with directors dealing with a proxy fight from the company's estranged founder, a big-name activist investor waiting for its opportunity, and the board being pushed to recruit a new CEO, WSJ saysBPis reviewing possible sale of North Sea assets, Bloomberg says4. MOVERS:Esperiongained after entering an agreement to befor $3.16 per shareFive9increased afterand providing guidance for FY26 and Q2Cerusand Atlassianwere higher afterSummit Therapeuticsand Ryan Specialtywere lower afterAlignment Healthcarefell afterand providing guidance for Q25. EARNINGS/GUIDANCE:Gates Industrial, with CEO Ivo Jurek commenting, "We executed well in the first quarter"Moderna, with EPS and revenue beating consensusTerex, with CEO Simon Meester commenting, "We are off to a good start and executing to plan"AutoNation, with EPS beating consensusColgate-Palmoliveand backed its guidance for FY26INDEXES:The Dow fell 152.87, or 0.31%, to 49,499.27, the Nasdaq gained 222.13, or 0.89%, to 25,114.44, and the S&P 500 advanced 21.11, or 0.29%, to 7,230.12.
05/01 12:10
Summit Therapeutics Shares Drop 23.7% to $16.38
Summit Therapeutics is down -23.7%, or -$5.08 to $16.38.

SMMT Monitor News

Summit Therapeutics Reports Wider Q1 Loss Amid Clinical Progress

May 01 2026

Summit Therapeutics Inc. hits a 5-day low amid market decline

Apr 23 2026

Summit Therapeutics Inc. stock falls amid market gains

Apr 22 2026

Summit Therapeutics reaches 20-day high amid market gains

Apr 21 2026

Summit Therapeutics Inc. reaches 20-day high amid market gains

Apr 16 2026

Summit Therapeutics Inc. stock rises after crossing above SMA

Mar 25 2026

Summit Therapeutics Grants Stock Options to New Employees

Jan 12 2026

SMMT Earnings Analysis

Summit Therapeutics: 2024 Earnings & Oncology Advances- Intellectia AI™
1 years ago

People Also Watch